Search results
Results from the WOW.Com Content Network
For children, intravenous patient-controlled analgesia (IV-PCA) can be used when parenteral administration is preferred. [38] IV-PCA allows for consistent opioid levels, which can be a better alternative to scheduled intramuscular injections. [1] In addition, studies have shown that children as young as 6 years old can use the IV-PCA correctly ...
The exact medications recommended will vary by country and the individual treatment center, but the following gives an example of the WHO approach to treating chronic pain with medications. If, at any point, treatment fails to provide adequate pain relief, then the doctor and patient move onto the next step.
It is sold over-the-counter in Canada and the United States; [17] [19] in the United Kingdom, it is a prescription-only medication. [15] In Australia and the European Union, it is indicated for difficulty sleeping in people over the age of 54. [23] [8] In the European Union, it is indicated for the treatment of insomnia in children and ...
For some types of cancer, young adults may have better outcomes if treated with pediatric, rather than adult, treatment regimens. Young adults who have a cancer that typically occurs in children and adolescents, such as brain tumors, leukemia, osteosarcoma, and Ewing sarcoma, may fare better if treated by a pediatric oncologist.
Chlorpromazine is occasionally used off-label for treatment of severe migraine. [19] [20] It is often, particularly as palliation, used in small doses to reduce nausea by opioid-treated cancer patients and to intensify and prolong the analgesia of the opioids as well. [19] [21] Efficacy has been shown in treatment of symptomatic hypertensive ...
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.
Dec. 10—ROCHESTER — Cris Ross, Mayo Clinic's high-profile information technology chief who managed the $1.5 billion Epic System medical records transition, retired in November. Ross had served ...
Viadur was approved by the FDA for palliative treatment of advanced prostate cancer on 6 March 2000. [7] Eligard was approved by the FDA for palliative treatment of advanced prostate cancer on 24 January 2002. [5] Fensolvi was approved by the FDA for children with central precocious puberty on 4 May 2020. [6] [46]